Role of SHP2 phosphatase in KIT-induced transformation: Identification of SHP2 as a druggable target in diseases involving oncogenic KIT

Department of Pediatrics, Herman B. Wells Center for Pediatric Research and.
Blood (Impact Factor: 10.45). 07/2012; 120(13):2669-78. DOI: 10.1182/blood-2011-08-375873
Source: PubMed


Intracellular mechanism(s) that contribute to promiscuous signaling via oncogenic KIT in systemic mastocytosis and acute myelogenous leukemia are poorly understood. We show that SHP2 phosphatase is essential for oncogenic KIT-induced growth and survival in vitro and myeloproliferative disease (MPD) in vivo. Genetic disruption of SHP2 or treatment of oncogene-bearing cells with a novel SHP2 inhibitor alone or in combination with the PI3K inhibitor corrects MPD by disrupting a protein complex involving p85α, SHP2, and Gab2. Importantly, a single tyrosine at position 719 in oncogenic KIT is sufficient to develop MPD by recruiting p85α, SHP2, and Gab2 complex to oncogenic KIT. Our results demonstrate that SHP2 phosphatase is a druggable target that cooperates with lipid kinases in inducing MPD.

Download full-text


Available from: Raghuveer Singh Mali, Oct 01, 2015
52 Reads
  • Source
  • Blood 09/2012; 120(13):2541-2. DOI:10.1182/blood-2012-08-445247 · 10.45 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: The protein tyrosine phosphatase, Shp2, is widely expressed; however, previous studies demonstrated that hematopoietic cell development more stringently requires Shp2 expression compared to other tissues. Furthermore, somatic gain-of-function Shp2 mutants are commonly found in human myeloid leukemias. Given that pharmacologic inhibitors to Shp2 phosphatase activity are currently in development as putative anti-leukemic agents, we conducted a series of experiments examining the necessity of Shp2 phosphatase activity for human hematopoiesis. Anti-sense oligonucleotides to human Shp2 coding sequences reduced human cord blood- and human cell line, TF1-derived colony formation. Expression of truncated Shp2 bearing its Src homology 2 (SH2) domains but lacking the phosphatase domain similarly reduced human cord blood- and TF1-derived colony formation. Mechanistically, expression of truncated Shp2 reduced the interaction between endogenous, full-length Shp2 with the adapter protein, Grb2. To verify the role of Shp2 phosphatase function in human hematopoietic cell development, human cord blood CD34+ cells were transduced with a leukemia-associated phosphatase gain-of-function Shp2 mutant or with a phosphatase dead Shp2 mutant, which indicated that increased phosphatase function enhanced, while decreased Shp2 phosphatase function reduced, human cord blood-derived colonies. Collectively, these findings indicate that Shp2 phosphatase function regulates human hematopoietic cell development and imply that the phosphatase component of Shp2 may serve as a pharmacologic target in human leukemias bearing increased Shp2 phosphatase activity.
    Stem cells and development 10/2012; 22(6). DOI:10.1089/scd.2012.0478 · 3.73 Impact Factor
Show more